On September 14, Plastidine Biotech announced the completion of the C+ round of financing of nearly 300 million yuan. This round of financing was led by Kaihui Fund, followed by Huatai Zijin. The investments of old shareholders Tencent and Lichen continued to increase.

On September 14, Plastidine Biotech announced the completion of the C+ round of financing of nearly 300 million yuan. This round of financing was led by Kaihui Fund, followed by Huatai Zijin. The investments of old shareholders Tencent and Lichen continued to increase.